SE539744C2 - PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE - Google Patents
PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE Download PDFInfo
- Publication number
- SE539744C2 SE539744C2 SE1530127A SE1530127A SE539744C2 SE 539744 C2 SE539744 C2 SE 539744C2 SE 1530127 A SE1530127 A SE 1530127A SE 1530127 A SE1530127 A SE 1530127A SE 539744 C2 SE539744 C2 SE 539744C2
- Authority
- SE
- Sweden
- Prior art keywords
- glucose
- syringe
- fluid
- ultrafiltration
- peritoneal
- Prior art date
Links
- 238000000108 ultra-filtration Methods 0.000 title claims abstract description 71
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 179
- 239000008103 glucose Substances 0.000 claims abstract description 173
- 239000012530 fluid Substances 0.000 claims abstract description 81
- 210000003200 peritoneal cavity Anatomy 0.000 claims abstract description 62
- 210000003567 ascitic fluid Anatomy 0.000 claims abstract description 43
- 238000010790 dilution Methods 0.000 claims abstract description 38
- 239000012895 dilution Substances 0.000 claims abstract description 38
- 239000012141 concentrate Substances 0.000 claims abstract description 23
- 206010007559 Cardiac failure congestive Diseases 0.000 claims abstract description 11
- 206010019280 Heart failures Diseases 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 238000001802 infusion Methods 0.000 claims description 7
- 238000005192 partition Methods 0.000 claims description 3
- 230000000670 limiting effect Effects 0.000 claims description 2
- 238000007912 intraperitoneal administration Methods 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 24
- 238000002156 mixing Methods 0.000 description 15
- 238000000502 dialysis Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 238000011282 treatment Methods 0.000 description 11
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 210000004379 membrane Anatomy 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 230000009102 absorption Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000002357 osmotic agent Substances 0.000 description 6
- 230000009103 reabsorption Effects 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 230000001926 lymphatic effect Effects 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 230000037452 priming Effects 0.000 description 5
- 239000002594 sorbent Substances 0.000 description 5
- 208000001953 Hypotension Diseases 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 239000000385 dialysis solution Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920002177 Icodextrin Polymers 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 108010046334 Urease Proteins 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000036543 hypotension Effects 0.000 description 3
- 229940016836 icodextrin Drugs 0.000 description 3
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 3
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 3
- 206010016803 Fluid overload Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 239000003330 peritoneal dialysis fluid Substances 0.000 description 2
- 206010034674 peritonitis Diseases 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000004990 Cardiorenal syndrome Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000009378 Low Cardiac Output Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/287—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/281—Instillation other than by gravity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/282—Operational modes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/285—Catheters therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1017—Peritoneal cavity
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1530127A SE539744C2 (en) | 2015-08-27 | 2015-08-27 | PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE |
| CA2996071A CA2996071C (en) | 2015-08-27 | 2016-08-26 | Apparatus for performing peritoneal ultrafiltration |
| EP16839697.6A EP3341043B1 (en) | 2015-08-27 | 2016-08-26 | Apparatus for performing peritoneal ultrafiltration |
| CN201680049811.8A CN108136098B (zh) | 2015-08-27 | 2016-08-26 | 用于执行腹膜超滤的设备 |
| BR112018003281A BR112018003281A2 (pt) | 2015-08-27 | 2016-08-26 | aparelho para realizar ultrafiltração de um paciente, e método para realizar ultrafiltração de um paciente |
| US15/755,472 US10946130B2 (en) | 2015-08-27 | 2016-08-26 | Apparatus for performing peritoneal ultrafiltration |
| JP2018510792A JP6869551B2 (ja) | 2015-08-27 | 2016-08-26 | 腹膜限外濾過を実行するための装置 |
| AU2016312860A AU2016312860B2 (en) | 2015-08-27 | 2016-08-26 | Apparatus for performing peritoneal ultrafiltration |
| PCT/SE2016/000043 WO2017034452A1 (en) | 2015-08-27 | 2016-08-26 | Apparatus for performing peritoneal ultrafiltration |
| ES16839697T ES2839174T3 (es) | 2015-08-27 | 2016-08-26 | Aparato para realizar la ultrafiltración peritoneal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1530127A SE539744C2 (en) | 2015-08-27 | 2015-08-27 | PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE1530127A1 SE1530127A1 (en) | 2017-02-28 |
| SE539744C2 true SE539744C2 (en) | 2017-11-14 |
Family
ID=58100764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE1530127A SE539744C2 (en) | 2015-08-27 | 2015-08-27 | PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10946130B2 (enExample) |
| EP (1) | EP3341043B1 (enExample) |
| JP (1) | JP6869551B2 (enExample) |
| CN (1) | CN108136098B (enExample) |
| AU (1) | AU2016312860B2 (enExample) |
| BR (1) | BR112018003281A2 (enExample) |
| CA (1) | CA2996071C (enExample) |
| ES (1) | ES2839174T3 (enExample) |
| SE (1) | SE539744C2 (enExample) |
| WO (1) | WO2017034452A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8202248B2 (en) | 2004-08-18 | 2012-06-19 | Sequana Medical Ag | Dialysis implant and methods of use |
| US9750862B2 (en) | 2011-04-29 | 2017-09-05 | Medtronic, Inc. | Adaptive system for blood fluid removal |
| US8585635B2 (en) | 2012-02-15 | 2013-11-19 | Sequana Medical Ag | Systems and methods for treating chronic liver failure based on peritoneal dialysis |
| WO2016080883A1 (en) * | 2014-11-21 | 2016-05-26 | Triomed Ab | Apparatus for performing peritoneal ultrafiltration |
| US10994064B2 (en) | 2016-08-10 | 2021-05-04 | Medtronic, Inc. | Peritoneal dialysate flow path sensing |
| US12329892B2 (en) | 2016-04-04 | 2025-06-17 | Mozarc Medical Us Llc | Dextrose concentration sensor for a peritoneal dialysis system |
| US10874790B2 (en) * | 2016-08-10 | 2020-12-29 | Medtronic, Inc. | Peritoneal dialysis intracycle osmotic agent adjustment |
| WO2017176695A1 (en) | 2016-04-04 | 2017-10-12 | Medtronic, Inc. | Peritoneal dialysate fluid generation system |
| US10758659B2 (en) | 2016-08-10 | 2020-09-01 | Medtronic, Inc. | Peritoneal dialysis filtrate sampling and adaptive prescription |
| US10537673B2 (en) | 2016-08-10 | 2020-01-21 | Medtronic, Inc. | Intersession adaptive peritoneal dialysis fluid removal for multiple session optimization |
| US10744253B2 (en) | 2016-08-10 | 2020-08-18 | Medtronic, Inc. | Adaptive peritoneal dialysis intra-session adjustments for overall session optimization |
| CN110249389A (zh) | 2016-08-26 | 2019-09-17 | 塞奎阿纳医疗股份公司 | 用于管理和分析由可植入设备生成的数据的系统和方法 |
| US11013843B2 (en) | 2016-09-09 | 2021-05-25 | Medtronic, Inc. | Peritoneal dialysis fluid testing system |
| US11559618B2 (en) | 2017-05-24 | 2023-01-24 | Sequana Medical Nv | Formulations and methods for direct sodium removal in patients having severe renal dysfunction |
| AU2018273105B2 (en) * | 2017-05-24 | 2023-08-10 | Dsrco Bv | Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients |
| US11179516B2 (en) | 2017-06-22 | 2021-11-23 | Baxter International Inc. | Systems and methods for incorporating patient pressure into medical fluid delivery |
| CN109432523A (zh) * | 2018-11-13 | 2019-03-08 | 重庆本善医疗设备有限公司 | 用浓缩液在线连续稀释生成腹透液的装置及方法 |
| US11806456B2 (en) | 2018-12-10 | 2023-11-07 | Mozarc Medical Us Llc | Precision peritoneal dialysis therapy based on dialysis adequacy measurements |
| EP3912656A1 (en) * | 2020-05-19 | 2021-11-24 | CoreQuest Sagl | Peritoneal dialysis solution |
| US12154673B2 (en) | 2021-08-02 | 2024-11-26 | Mozarc Medical Us Llc | Artificial intelligence assisted home therapy settings for dialysis |
| US11850344B2 (en) | 2021-08-11 | 2023-12-26 | Mozarc Medical Us Llc | Gas bubble sensor |
| US11965763B2 (en) | 2021-11-12 | 2024-04-23 | Mozarc Medical Us Llc | Determining fluid flow across rotary pump |
| US20260041831A1 (en) * | 2022-08-24 | 2026-02-12 | Awak Technologies Pte Ltd | Method and apparatus |
| CN117462779A (zh) * | 2023-11-22 | 2024-01-30 | 中国船舶集团有限公司第七一六研究所 | 一种便携式人工肾葡萄糖高精度增补系统 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1462349A (en) * | 1921-09-14 | 1923-07-17 | Charles M Mccarthy | Wire-cloth-display roll rack |
| GB1462349A (en) * | 1974-01-17 | 1977-01-26 | Hydronautics | Devices for continuously removing toxic metabolites from blood |
| DE3333362C2 (de) * | 1983-09-15 | 1986-03-20 | Fresenius AG, 6380 Bad Homburg | Peritonealdialysegerät |
| US4747822A (en) * | 1984-07-09 | 1988-05-31 | Peabody Alan M | Continuous flow peritoneal dialysis system and method |
| CH660464A5 (fr) * | 1984-11-21 | 1987-04-30 | Bobst Sa | Machine de traitement d'une matiere en bande. |
| DE68911517T2 (de) | 1989-06-15 | 1994-05-26 | Alan M Peabody | System zur kontinuierlichen zyklischen Peritonealdialyse. |
| US5141493A (en) | 1990-01-26 | 1992-08-25 | Sarcos Group | Peritoneal dialysis system |
| EP0498382B1 (en) | 1991-02-08 | 1996-11-13 | Alan M. Peabody | Continuous peritoneal dialysis system |
| ES2162923T3 (es) | 1994-06-17 | 2002-01-16 | Baxter Int | Metodo y aparato para dialisis peritoneal de impulso depurado. |
| US5944684A (en) | 1995-08-31 | 1999-08-31 | The Regents Of The University Of California | Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications |
| CA2211848C (en) * | 1997-07-28 | 2002-06-11 | Joseph E. Dadson | Peritoneal dialysis apparatus |
| US6228047B1 (en) * | 1997-07-28 | 2001-05-08 | 1274515 Ontario Inc. | Method and apparatus for performing peritoneal dialysis |
| JP2000254223A (ja) * | 1999-03-10 | 2000-09-19 | Nikkiso Co Ltd | 自動流体移送装置 |
| SE9901165D0 (sv) | 1999-03-30 | 1999-03-30 | Gambro Lundia Ab | Method, apparatus and components of dialysis systems |
| US6758975B2 (en) * | 2001-02-16 | 2004-07-06 | Piedmont Renal Clinic, Pa | Automated peritoneal dialysis system and process with in-line sterilization of dialysate |
| JP4129726B2 (ja) * | 2002-07-17 | 2008-08-06 | ニプロ株式会社 | 腹膜透析装置 |
| US7135008B2 (en) | 2003-12-02 | 2006-11-14 | Chf Solutions, Inc. | Method and apparatus for ultrafiltration utilizing a peripheral access dual lumen venous cannula |
| NZ569493A (en) * | 2006-01-30 | 2011-12-22 | Univ California | Peritoneal dialysis methods and apparatus |
| US8012118B2 (en) * | 2006-03-08 | 2011-09-06 | Fresenius Medical Care Holdings, Inc. | Artificial kidney dialysis system |
| US8715221B2 (en) * | 2006-03-08 | 2014-05-06 | Fresenius Medical Care Holdings, Inc. | Wearable kidney |
| CA2574537C (en) * | 2007-01-19 | 2014-03-25 | Joseph E. Dadson, Sr. | System and method for peritoneal dialysis |
| US20100312174A1 (en) * | 2009-06-06 | 2010-12-09 | Hoffman Josef C A | Peritoneal Dialysis System |
| DE102009051805A1 (de) * | 2009-11-03 | 2011-05-05 | Gambro Lundia Ab | Dialysevorrichtungen mit Piezopumpen |
| WO2013070172A1 (en) * | 2011-11-08 | 2013-05-16 | Temasek Polytechnic | Sensing system for detecting a substance in a dialysate |
| US9624915B2 (en) * | 2011-03-09 | 2017-04-18 | Fresenius Medical Care Holdings, Inc. | Medical fluid delivery sets and related systems and methods |
| JP6049685B2 (ja) | 2011-03-23 | 2016-12-21 | ネクステージ メディカル インコーポレイテッド | 腹膜透析使い捨てユニット、コントローラ、腹膜透析システム |
| CA2862208A1 (en) | 2012-01-19 | 2013-07-25 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
| SE538124C2 (sv) | 2014-02-28 | 2016-03-08 | Triomed Ab | Apparat för peritoneal ultrafiltration innefattande kontrollav glukoskoncentrationen i peritonealhålan |
-
2015
- 2015-08-27 SE SE1530127A patent/SE539744C2/en unknown
-
2016
- 2016-08-26 CN CN201680049811.8A patent/CN108136098B/zh active Active
- 2016-08-26 BR BR112018003281A patent/BR112018003281A2/pt not_active Application Discontinuation
- 2016-08-26 EP EP16839697.6A patent/EP3341043B1/en active Active
- 2016-08-26 CA CA2996071A patent/CA2996071C/en active Active
- 2016-08-26 WO PCT/SE2016/000043 patent/WO2017034452A1/en not_active Ceased
- 2016-08-26 ES ES16839697T patent/ES2839174T3/es active Active
- 2016-08-26 US US15/755,472 patent/US10946130B2/en active Active
- 2016-08-26 AU AU2016312860A patent/AU2016312860B2/en active Active
- 2016-08-26 JP JP2018510792A patent/JP6869551B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SE1530127A1 (en) | 2017-02-28 |
| WO2017034452A1 (en) | 2017-03-02 |
| CA2996071A1 (en) | 2017-03-02 |
| JP2018529414A (ja) | 2018-10-11 |
| EP3341043A4 (en) | 2019-02-20 |
| EP3341043B1 (en) | 2020-10-07 |
| CN108136098B (zh) | 2021-11-30 |
| US10946130B2 (en) | 2021-03-16 |
| AU2016312860A1 (en) | 2018-03-15 |
| JP6869551B2 (ja) | 2021-05-12 |
| BR112018003281A2 (pt) | 2018-09-18 |
| ES2839174T3 (es) | 2021-07-05 |
| AU2016312860B2 (en) | 2021-02-04 |
| CA2996071C (en) | 2023-12-19 |
| EP3341043A1 (en) | 2018-07-04 |
| CN108136098A (zh) | 2018-06-08 |
| US20180169318A1 (en) | 2018-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE1530127A1 (en) | PERFORMING PERITONEAL ULTRAFILTRATION APPLIANCE | |
| US11590269B2 (en) | Apparatus for performing peritoneal ultrafiltration | |
| US10744249B2 (en) | Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection | |
| US10532141B2 (en) | Systems and methods for multifunctional volumetric fluid control | |
| ES2266160T3 (es) | Metodo y aparato para monitorizar y controlar la terapia de dialisis peritoneal. | |
| US9173987B2 (en) | Degassing module for a controlled compliant flow path | |
| US4560472A (en) | Peritoneal dialysis apparatus | |
| US9526822B2 (en) | Sodium and buffer source cartridges for use in a modular controlled compliant flow path | |
| US10709831B2 (en) | Method and apparatus for performing peritoneal ultrafiltration | |
| CN104968376A (zh) | 用于递送肾替代疗法的流体回路 | |
| JP2025501160A (ja) | 減少されたｐＨ消毒を有する腹膜透析循環装置 | |
| US12383663B2 (en) | Peritoneal dialysis system having carbon dioxide injection to inhibit/remove calcium carbonate | |
| US20230414851A1 (en) | Dialysis system having a disinfection unit |